Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
NCT04870424Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Sep 2021
- Primary completion
- May 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in Atrial fibrillation (AFib), cardiac conduction disorder, sponsored by Insel Gruppe. Started Sep 2021; status: completed.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)cardiac conduction disorder
Beyond the preview
Go deeper on NCT04870424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04870424.